ReviewExtracellular vesicles and circulating nucleic acids2025
Microfluidic devices for on-chip quantification of extracellular vesicles and associated biomarkers.
Review in Extracellular vesicles and circulating nucleic acids, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- From pathogenic to reparative: Context-Dependent function of extracellular vesicles in osteoarthritis.Bioactive materials · 2027Review
- Review
- Advanced Technologies in Extracellular Vesicle Biosensing: Platforms, Standardization, and Clinical Translation.Molecules (Basel, Switzerland) · 2026Review
- Conditioned Media-Derived Tumor Extracellular Vesicles: Bridging Molecular Insights and Therapeutic Applications in Oncology.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the past decade, extracellular vesicles (EVs) have gained increasing attention in biomedical research. These membrane-bound particles are naturally secreted by cells under both physiological and pathological conditions, and they exhibit a wide range of sizes and molecular compositions. EVs transport bioactive molecules - such as proteins, nucleic acids, and lipids - making them ideal candidates for biomarker discovery. Consequently, their accurate characterization and quantification are critical for understanding their roles in intercellular communication and evaluating their potential in diagnostics, prognostics, disease monitoring, and therapeutic applications. Microfluidic technologies offer promising solutions for EV analysis, addressing key limitations of conventional methods by enabling precise and sensitive measurements with small sample volumes. While microfluidic devices have been predominantly used for EV separation and isolation, their application in EV quantification remains underexplored. Compared to traditional techniques like nanoparticle tracking analysis or flow cytometry, microfluidic systems can provide faster, more accessible alternatives for EV quantification. This review summarizes recent advances in microfluidic technologies for EV quantification, discussing their advantages, current limitations, and future prospects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.